Skip to main content
EVRYSDI .75 mg/mL powder, for solution by Genentech, Inc.
EVRYSDI, .75 mg/mL, powder, for solution Drug class: Survival of Motor Neuron 2 Splicing Modifier. Available on prescription only. Listed by Genentech, Inc..
Prescription only

EVRYSDI

Risdiplam

Listed by Genentech, Inc.

Strength
.75 mg/mL
Form
Powder, For Solution
Route
Oral
Class
Survival of Motor Neuron 2 Splicing Modifier

What it contains

  • Risdiplam .75 mg/mL

FDA record

Dosage form Powder, For Solution
Route Oral
Drug class Survival of Motor Neuron 2 Splicing Modifier
Approval route NDA — original brand approval
NDC code 50242-175
FDA application NDA213535
RxNorm concept 2390940
Package sizes listed 1
Marketed since August 2020

Other products containing Risdiplam

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

EVRYSDI

Risdiplam

Strength
5 mg/1
Form
Tablet
Class
Survival of Motor Neuron 2 Splicing Mod…
Rx only

Genentech, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.